![Roy Green Show artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts123/v4/3c/ac/83/3cac8311-c716-9c0d-4c1e-b9e660bfdea5/mza_5366807072502183981.jpg/100x100bb.jpg)
Jan 7: Fmr Pres/CEO GSK Pharmaceuticals. Paul Lucas on Vaccines/Covid.
Roy Green Show
English - January 07, 2023 22:09 - 12 minutes - ★★★★ - 3 ratingsNews Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
According to the WHO and national public health in Canada the Covid variant XBB.1.5 is the new threat to health globally and here in Canada. (Tomorrow we'll get deeper into this XBB variant threat)
How do pharmaceutical companies create new vaccines, boosters and other anti-viral treatments for Covid variants for a complete age range of Canadians when we don't know until the variant is established that it's present in the population? Are governments and particularly the current federal government a help or hindrance?
Guest: Paul Lucas. Former president/CEO of Glaxo Smith Kline, Canada.
Learn more about your ad choices. Visit megaphone.fm/adchoices
According to the WHO and national public health in Canada the Covid variant XBB.1.5 is the new threat to health globally and here in Canada. (Tomorrow we'll get deeper into this XBB variant threat)
How do pharmaceutical companies create new vaccines, boosters and other anti-viral treatments for Covid variants for a complete age range of Canadians when we don't know until the variant is established that it's present in the population? Are governments and particularly the current federal government a help or hindrance?
Guest: Paul Lucas. Former president/CEO of Glaxo Smith Kline, Canada.
Learn more about your ad choices. Visit megaphone.fm/adchoices